Full Text
HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021

Abstract

Authors

M Meregaglia F Malandrini C Borroni O Ciani

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×